American Century Companies Inc. Buys 1,027,991 Shares of Ralliant Corporation $RAL

American Century Companies Inc. lifted its position in shares of Ralliant Corporation (NYSE:RAL) by 619.2% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,193,997 shares of the company’s stock after purchasing an additional 1,027,991 shares during the quarter. American Century Companies Inc.’s holdings in Ralliant were worth $52,214,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Huntington National Bank acquired a new position in shares of Ralliant during the 3rd quarter worth about $103,000. Quantbot Technologies LP bought a new stake in Ralliant during the third quarter worth about $3,033,000. Aster Capital Management DIFC Ltd acquired a new position in Ralliant during the third quarter valued at approximately $143,000. 1ST Source Bank acquired a new position in Ralliant during the third quarter valued at approximately $298,000. Finally, Choreo LLC grew its stake in Ralliant by 9.9% in the third quarter. Choreo LLC now owns 6,063 shares of the company’s stock valued at $265,000 after purchasing an additional 546 shares in the last quarter.

Ralliant Stock Down 1.4%

RAL stock opened at $46.36 on Friday. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02. The business has a 50-day simple moving average of $49.08 and a 200 day simple moving average of $46.63. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. The company has a market cap of $5.18 billion and a PE ratio of 23.65.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping the consensus estimate of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. Ralliant’s revenue for the quarter was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio is presently 10.20%.

Insider Transactions at Ralliant

In other news, Director Anelise Angelino Sacks purchased 2,000 shares of the company’s stock in a transaction dated Monday, February 9th. The shares were purchased at an average price of $41.25 per share, for a total transaction of $82,500.00. Following the transaction, the director owned 5,403 shares of the company’s stock, valued at approximately $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Karen M. Bick sold 5,485 shares of the business’s stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total value of $246,825.00. Following the completion of the transaction, the senior vice president directly owned 46,756 shares in the company, valued at approximately $2,104,020. This trade represents a 10.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have purchased 8,145 shares of company stock worth $332,233.

Wall Street Analysts Forecast Growth

RAL has been the topic of a number of analyst reports. Citigroup dropped their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Truist Financial lowered their target price on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Morgan Stanley reiterated an “overweight” rating and issued a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Royal Bank Of Canada decreased their price objective on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a research report on Friday, February 6th. Finally, Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective on the stock in a research note on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $50.50.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.